Cargando…
O15 Tumour-induced osteomalacia: a diagnostic challenge
CASE REPORT - INTRODUCTION: Tumor-induced osteomalacia is a rare acquired metabolic bone disorder characterised by isolated renal phosphate wasting due to abnormal tumour production of fibroblast growth factor 23 (FGF23). Bloods show hypophosphatemia. However, given the lack of awareness of this dis...
Autores principales: | Khalid, Salema, Javaid, Kassim, Buchanan, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524173/ http://dx.doi.org/10.1093/rap/rkab067.014 |
Ejemplares similares
-
O24 Malignancy in antiphospholipid syndrome: a catastrophe
por: Khalid, Salema, et al.
Publicado: (2021) -
20. Tocilizumab: is out of sight really out of mind?
por: Khalid, Salema, et al.
Publicado: (2019) -
Imaging tumour response - challenges
por: Rasmussen, Finn
Publicado: (2015) -
Osteomalacia
Publicado: (1914) -
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia
por: Amarnani, Raj, et al.
Publicado: (2020)